Eugen Mengel1, Mercedes Pineda2, Christian J Hendriksz3, Mark Walterfang4, Juan V Torres5, Stefan A Kolb6. 1. ZKJM MC University Mainz, Mainz, Germany. Electronic address: mengel@kinder.klinik.uni-mainz.de. 2. Fundació, Hospital Sant Joan de Déu, Centre for Biomedical Research on Rare Diseases, CIBERER, Instituto de Salud Carlos III, Barcelona, Spain. 3. Salford Royal NHS Foundation Trust, Manchester, UK; University of Pretoria, Steve Biko Academic Unit, Department of Paediatrics and Child Health, Pretoria, South Africa. 4. Department of Neuropsychiatry, Royal Melbourne Hospital and Melbourne Neuropsychiatry Centre, University of Melbourne, Melbourne, Victoria, Australia. 5. Syntax for Science SL, Basel, Switzerland. 6. Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
Abstract
BACKGROUND: Niemann-Pick disease Type C (NP-C) is a genetic lipid storage disorder characterised by progressive neurovisceral symptomatology. Typically, disease progression is more pronounced in patients with early onset of neurological symptoms. Heterogeneous clinical presentation may hinder disease recognition and lead to delays in diagnosis. Here we describe the prevalence of signs and symptoms observed in patients with NP-C and analyse the relationship between these symptoms in different age groups. METHODS: The combined patient cohort used in the analyses comprised NP-C cases (n=164) and controls (n=135) aged 0 to 60years from two previously published cohorts; a cohort of all ages from which patients ≤4years of age were excluded and a cohort with early-onset NP-C and age-matched controls. The analysis of relationships between different signs and symptoms was performed for both NP-C cases and controls in two sub-groups, ≤4 and >4years of age, using cluster analyses. The threshold of 4years of age was selected to reflect the minimum age cut-off for satisfactory discriminatory power of the original NP-C SI. To assess the prevalence of individual signs and symptoms at age of diagnosis, patients were categorised by age into 5-year sub-groups, and prevalence values estimated for each sign and symptom of NP-C. RESULTS: Two main clusters of symptoms were clearly defined for NP-C cases in each age sub-group, whereas clusters were not as clearly defined for controls. For NP-C cases ≤4years of age, one cluster comprised exclusively visceral symptoms; the second cluster combined all other signs and symptoms in this age group. For NP-C cases >4years of age, each cluster contained a mixture of visceral, neurological and psychiatric items. Prevalence estimations showed that visceral symptoms (e.g. isolated unexplained splenomegaly) were most common in NP-C cases ≤4years of age. Neurological symptoms were generally more common in NP-C cases >4years of age than in younger patients, with the exception of hypotonia and delayed developmental milestones. CONCLUSIONS: These analyses provide a comprehensive overview of symptomatology observed in a large combined cohort of patients with NP-C and controls across a wide range of ages. The results largely reflect observations from clinical practice and support the importance of multi-disciplinary approaches for identification of patients with NP-C, taking into account age-specific manifestations and their possible correlations.
BACKGROUND:Niemann-Pick disease Type C (NP-C) is a genetic lipid storage disorder characterised by progressive neurovisceral symptomatology. Typically, disease progression is more pronounced in patients with early onset of neurological symptoms. Heterogeneous clinical presentation may hinder disease recognition and lead to delays in diagnosis. Here we describe the prevalence of signs and symptoms observed in patients with NP-C and analyse the relationship between these symptoms in different age groups. METHODS: The combined patient cohort used in the analyses comprised NP-C cases (n=164) and controls (n=135) aged 0 to 60years from two previously published cohorts; a cohort of all ages from which patients ≤4years of age were excluded and a cohort with early-onset NP-C and age-matched controls. The analysis of relationships between different signs and symptoms was performed for both NP-C cases and controls in two sub-groups, ≤4 and >4years of age, using cluster analyses. The threshold of 4years of age was selected to reflect the minimum age cut-off for satisfactory discriminatory power of the original NP-C SI. To assess the prevalence of individual signs and symptoms at age of diagnosis, patients were categorised by age into 5-year sub-groups, and prevalence values estimated for each sign and symptom of NP-C. RESULTS: Two main clusters of symptoms were clearly defined for NP-C cases in each age sub-group, whereas clusters were not as clearly defined for controls. For NP-C cases ≤4years of age, one cluster comprised exclusively visceral symptoms; the second cluster combined all other signs and symptoms in this age group. For NP-C cases >4years of age, each cluster contained a mixture of visceral, neurological and psychiatric items. Prevalence estimations showed that visceral symptoms (e.g. isolated unexplained splenomegaly) were most common in NP-C cases ≤4years of age. Neurological symptoms were generally more common in NP-C cases >4years of age than in younger patients, with the exception of hypotonia and delayed developmental milestones. CONCLUSIONS: These analyses provide a comprehensive overview of symptomatology observed in a large combined cohort of patients with NP-C and controls across a wide range of ages. The results largely reflect observations from clinical practice and support the importance of multi-disciplinary approaches for identification of patients with NP-C, taking into account age-specific manifestations and their possible correlations.
Authors: Elizabeth Berry-Kravis; Jamie Chin; Anne Hoffmann; Amy Winston; Robin Stoner; Lisa LaGorio; Katherine Friedmann; Mariana Hernandez; Daniel S Ory; Forbes D Porter; Joan A O'Keefe Journal: Pediatr Neurol Date: 2018-01-08 Impact factor: 3.372
Authors: Wei-Chia Tseng; Ana J Johnson Escauriza; Chon-Hwa Tsai-Morris; Benjamin Feldman; Ryan K Dale; Christopher A Wassif; Forbes D Porter Journal: Development Date: 2021-04-15 Impact factor: 6.868
Authors: Wei-Chia Tseng; Hannah E Loeb; Wuhong Pei; Chon-Hwa Tsai-Morris; Lisha Xu; Celine V Cluzeau; Christopher A Wassif; Benjamin Feldman; Shawn M Burgess; William J Pavan; Forbes D Porter Journal: Dis Model Mech Date: 2018-08-15 Impact factor: 5.758
Authors: Mercedes Pineda; Katarína Juríčková; Parvaneh Karimzadeh; Miriam Kolnikova; Vera Malinova; Jose Luis Insua; Christian Velten; Stefan A Kolb Journal: Orphanet J Rare Dis Date: 2019-01-08 Impact factor: 4.123
Authors: Dita Musalkova; Filip Majer; Ladislav Kuchar; Ondrej Luksan; Befekadu Asfaw; Hana Vlaskova; Gabriela Storkanova; Martin Reboun; Helena Poupetova; Helena Jahnova; Helena Hulkova; Jana Ledvinova; Lenka Dvorakova; Jakub Sikora; Milan Jirsa; Marie T Vanier; Martin Hrebicek Journal: Orphanet J Rare Dis Date: 2020-04-05 Impact factor: 4.123